BDSX

In the past six months, Biodesix's stock price has shown significant positive momentum, with a 328.08% increase over the last 12 months and a 28.96% increase in the past month as of September 17, 2026. However, the share price on September 11, 2026, was $26.96, representing an 82.26% decline from $152.00 on September 15, 2025, following a 1:20 reverse stock split on September 15, 2025. Recent events include Biodesix's Quality and Regulatory Executive speaking at RAPS and SOCRA Annual Meetings on September 14, 2026, and the company's announcement of participation in upcoming investor conferences on September 3, 2026. Major holder Jack W. Schuler bought 15,000 shares on August 13, 2026. On August 5, 2026, the company announced its Second Quarter 2026 results, reporting a 34% year-over-year revenue growth to $26.9 million and a GAAP EPS of -$0.71, beating estimates. Biodesix also participated in Canaccord Genuity's 46th Annual Growth Conference on August 4, 2026, and the stock experienced a significant daily move with a +32.56% change on May 4, 2026.